Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was characterized as a pandemic by the World Health Organization (WHO) in Dec. 2019. SARS-CoV-2 binds to the cell membrane through spike proteins on its surface and infects the cell. Furin, a host-cell enzyme, possesses a binding site for the spike protein. Thus, molecules that block furin could potentially be a therapeutic solution. Defensins are antimicrobial peptides that can hypothetically inhibit furin because of their arginine-rich structure. Theta-defensins, a subclass of defensins, have attracted attention as drug candidates due to their small size, unique structure, and involvement in several defense mechanisms. Theta-defensins could be a potential treatment for COVID-19 through furin inhibition and an anti-inflammatory mechanism. Note that inflammatory events are a significant and deadly condition that could happen at the later stages of COVID-19 infection. Here, the potential of theta-defensins against SARS-CoV-2 infection was investigated through in silico approaches. Based on docking analysis results, theta-defensins can function as furin inhibitors. Additionally, a novel candidate peptide against COVID-19 with optimal properties regarding antigenicity, stability, electrostatic potential, and binding strength was proposed. Further in vitro / in vivo investigations could verify the efficiency of the designed novel peptide.
【초록키워드】 COVID-19, coronavirus disease, SARS-CoV-2, Coronavirus disease 2019, coronavirus, pandemic, Anti-inflammatory, furin, arginine, SARS-COV-2 infection, peptide, docking, in vitro, severe acute respiratory syndrome Coronavirus, Spike protein, binding site, stability, COVID-19 infection, therapeutic, peptides, antimicrobial peptides, defensin, WHO, mechanisms, antigenicity, respiratory, molecules, in vivo, docking analysis, mechanism, binding, Analysis, Inflammatory, Potential treatment, Spike proteins, Efficiency, defense mechanisms, the cell, Health Organization, World Health Organization, acute respiratory syndrome, acute respiratory syndrome coronavirus, acute respiratory syndrome coronavirus 2, drug candidates, enzyme, Stage, subclass, furin inhibitors, drug candidate, Defense, antimicrobial peptide, cell membrane, infect, Cell, event, bind, caused, investigated, inhibit, characterized, unique, the spike protein, electrostatic, in silico approaches, 【제목키워드】 COVID-19, prediction, novel, Compound, counter,